Due to the COVID-19 pandemic, the global Rosiglitazone (CAS 122320-73-4) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Rosiglitazone Tablets accounting for % of the Rosiglitazone (CAS 122320-73-4) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

Rosiglitazone is more effective in controlling blood sugar and is suitable for the treatment of non-insulin-dependent (type II) diabetes.

Global Rosiglitazone (CAS 122320-73-4) Scope and Segment

Rosiglitazone (CAS 122320-73-4) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Rosiglitazone (CAS 122320-73-4) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Rosiglitazone Tablets

Rosiglitazone Maleate Tablets

Rosiglitazone Hydrochloride Tablets

Others

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

BY COMPANY

Hengrui Pharma

GSK

Taiji Group

Shengjitang Pharma

Huanghe Pharma

Wanma Pharma

Jingxin Pharma

STADA

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

1 Study Coverage

1.1 Rosiglitazone (CAS 122320-73-4) Product Introduction

1.2 Market by Type

1.2.1 Global Rosiglitazone (CAS 122320-73-4) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Rosiglitazone Tablets

1.2.3 Rosiglitazone Maleate Tablets

1.2.4 Rosiglitazone Hydrochloride Tablets

1.2.5 Others

1.3 Market by Application

1.3.1 Global Rosiglitazone (CAS 122320-73-4) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Rosiglitazone (CAS 122320-73-4) Sales Estimates and Forecasts 2017-2028

2.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Estimates and Forecasts 2017-2028

2.3 Global Rosiglitazone (CAS 122320-73-4) Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Rosiglitazone (CAS 122320-73-4) Sales by Region

2.4.1 Global Rosiglitazone (CAS 122320-73-4) Sales by Region (2017-2022)

2.4.2 Global Sales Rosiglitazone (CAS 122320-73-4) by Region (2023-2028)

2.5 Global Rosiglitazone (CAS 122320-73-4) Revenue by Region

2.5.1 Global Rosiglitazone (CAS 122320-73-4) Revenue by Region (2017-2022)

2.5.2 Global Rosiglitazone (CAS 122320-73-4) Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Rosiglitazone (CAS 122320-73-4) Sales by Manufacturers

3.1.1 Global Top Rosiglitazone (CAS 122320-73-4) Manufacturers by Sales (2017-2022)

3.1.2 Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rosiglitazone (CAS 122320-73-4) in 2021

3.2 Global Rosiglitazone (CAS 122320-73-4) Revenue by Manufacturers

3.2.1 Global Rosiglitazone (CAS 122320-73-4) Revenue by Manufacturers (2017-2022)

3.2.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Rosiglitazone (CAS 122320-73-4) Revenue in 2021

3.3 Global Rosiglitazone (CAS 122320-73-4) Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Rosiglitazone (CAS 122320-73-4) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Rosiglitazone (CAS 122320-73-4) Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Rosiglitazone (CAS 122320-73-4) Sales by Type

4.1.1 Global Rosiglitazone (CAS 122320-73-4) Historical Sales by Type (2017-2022)

4.1.2 Global Rosiglitazone (CAS 122320-73-4) Forecasted Sales by Type (2023-2028)

4.1.3 Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2017-2028)

4.2 Global Rosiglitazone (CAS 122320-73-4) Revenue by Type

4.2.1 Global Rosiglitazone (CAS 122320-73-4) Historical Revenue by Type (2017-2022)

4.2.2 Global Rosiglitazone (CAS 122320-73-4) Forecasted Revenue by Type (2023-2028)

4.2.3 Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Type (2017-2028)

4.3 Global Rosiglitazone (CAS 122320-73-4) Price by Type

4.3.1 Global Rosiglitazone (CAS 122320-73-4) Price by Type (2017-2022)

4.3.2 Global Rosiglitazone (CAS 122320-73-4) Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Rosiglitazone (CAS 122320-73-4) Sales by Application

5.1.1 Global Rosiglitazone (CAS 122320-73-4) Historical Sales by Application (2017-2022)

5.1.2 Global Rosiglitazone (CAS 122320-73-4) Forecasted Sales by Application (2023-2028)

5.1.3 Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2017-2028)

5.2 Global Rosiglitazone (CAS 122320-73-4) Revenue by Application

5.2.1 Global Rosiglitazone (CAS 122320-73-4) Historical Revenue by Application (2017-2022)

5.2.2 Global Rosiglitazone (CAS 122320-73-4) Forecasted Revenue by Application (2023-2028)

5.2.3 Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Application (2017-2028)

5.3 Global Rosiglitazone (CAS 122320-73-4) Price by Application

5.3.1 Global Rosiglitazone (CAS 122320-73-4) Price by Application (2017-2022)

5.3.2 Global Rosiglitazone (CAS 122320-73-4) Price Forecast by Application (2023-2028)

6 North America

6.1 North America Rosiglitazone (CAS 122320-73-4) Market Size by Type

6.1.1 North America Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)

6.1.2 North America Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)

6.2 North America Rosiglitazone (CAS 122320-73-4) Market Size by Application

6.2.1 North America Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)

6.2.2 North America Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)

6.3 North America Rosiglitazone (CAS 122320-73-4) Market Size by Country

6.3.1 North America Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2028)

6.3.2 North America Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Rosiglitazone (CAS 122320-73-4) Market Size by Type

7.1.1 Europe Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)

7.1.2 Europe Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)

7.2 Europe Rosiglitazone (CAS 122320-73-4) Market Size by Application

7.2.1 Europe Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)

7.2.2 Europe Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)

7.3 Europe Rosiglitazone (CAS 122320-73-4) Market Size by Country

7.3.1 Europe Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2028)

7.3.2 Europe Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Rosiglitazone (CAS 122320-73-4) Market Size by Type

8.1.1 Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)

8.1.2 Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)

8.2 Asia Pacific Rosiglitazone (CAS 122320-73-4) Market Size by Application

8.2.1 Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)

8.2.2 Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)

8.3 Asia Pacific Rosiglitazone (CAS 122320-73-4) Market Size by Region

8.3.1 Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Region (2017-2028)

8.3.2 Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Rosiglitazone (CAS 122320-73-4) Market Size by Type

9.1.1 Latin America Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)

9.1.2 Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)

9.2 Latin America Rosiglitazone (CAS 122320-73-4) Market Size by Application

9.2.1 Latin America Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)

9.2.2 Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)

9.3 Latin America Rosiglitazone (CAS 122320-73-4) Market Size by Country

9.3.1 Latin America Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2028)

9.3.2 Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Market Size by Type

10.1.1 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)

10.1.2 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)

10.2 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Market Size by Application

10.2.1 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)

10.2.2 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)

10.3 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Market Size by Country

10.3.1 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2028)

10.3.2 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Hengrui Pharma

11.1.1 Hengrui Pharma Corporation Information

11.1.2 Hengrui Pharma Overview

11.1.3 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Hengrui Pharma Recent Developments

11.2 GSK

11.2.1 GSK Corporation Information

11.2.2 GSK Overview

11.2.3 GSK Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 GSK Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GSK Recent Developments

11.3 Taiji Group

11.3.1 Taiji Group Corporation Information

11.3.2 Taiji Group Overview

11.3.3 Taiji Group Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Taiji Group Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Taiji Group Recent Developments

11.4 Shengjitang Pharma

11.4.1 Shengjitang Pharma Corporation Information

11.4.2 Shengjitang Pharma Overview

11.4.3 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Shengjitang Pharma Recent Developments

11.5 Huanghe Pharma

11.5.1 Huanghe Pharma Corporation Information

11.5.2 Huanghe Pharma Overview

11.5.3 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Huanghe Pharma Recent Developments

11.6 Wanma Pharma

11.6.1 Wanma Pharma Corporation Information

11.6.2 Wanma Pharma Overview

11.6.3 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Wanma Pharma Recent Developments

11.7 Jingxin Pharma

11.7.1 Jingxin Pharma Corporation Information

11.7.2 Jingxin Pharma Overview

11.7.3 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Jingxin Pharma Recent Developments

11.8 STADA

11.8.1 STADA Corporation Information

11.8.2 STADA Overview

11.8.3 STADA Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 STADA Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 STADA Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Rosiglitazone (CAS 122320-73-4) Industry Chain Analysis

12.2 Rosiglitazone (CAS 122320-73-4) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Rosiglitazone (CAS 122320-73-4) Production Mode & Process

12.4 Rosiglitazone (CAS 122320-73-4) Sales and Marketing

12.4.1 Rosiglitazone (CAS 122320-73-4) Sales Channels

12.4.2 Rosiglitazone (CAS 122320-73-4) Distributors

12.5 Rosiglitazone (CAS 122320-73-4) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Rosiglitazone (CAS 122320-73-4) Industry Trends

13.2 Rosiglitazone (CAS 122320-73-4) Market Drivers

13.3 Rosiglitazone (CAS 122320-73-4) Market Challenges

13.4 Rosiglitazone (CAS 122320-73-4) Market Restraints

14 Key Findings in The Global Rosiglitazone (CAS 122320-73-4) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Rosiglitazone (CAS 122320-73-4) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Rosiglitazone Tablets

Table 3. Major Manufacturers of Rosiglitazone Maleate Tablets

Table 4. Major Manufacturers of Rosiglitazone Hydrochloride Tablets

Table 5. Major Manufacturers of Others

Table 6. Global Rosiglitazone (CAS 122320-73-4) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Rosiglitazone (CAS 122320-73-4) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 8. Global Rosiglitazone (CAS 122320-73-4) Sales by Region (2017-2022) & (Kg)

Table 9. Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Region (2017-2022)

Table 10. Global Rosiglitazone (CAS 122320-73-4) Sales by Region (2023-2028) & (Kg)

Table 11. Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Region (2023-2028)

Table 12. Global Rosiglitazone (CAS 122320-73-4) Revenue by Region (2017-2022) & (US$ Million)

Table 13. Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Region (2017-2022)

Table 14. Global Rosiglitazone (CAS 122320-73-4) Revenue by Region (2023-2028) & (US$ Million)

Table 15. Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Region (2023-2028)

Table 16. Global Rosiglitazone (CAS 122320-73-4) Sales by Manufacturers (2017-2022) & (Kg)

Table 17. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Manufacturers (2017-2022)

Table 18. Global Rosiglitazone (CAS 122320-73-4) Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 19. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Manufacturers (2017-2022)

Table 20. Rosiglitazone (CAS 122320-73-4) Price by Manufacturers (2017-2022) &(USD/Kg)

Table 21. Global Rosiglitazone (CAS 122320-73-4) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Rosiglitazone (CAS 122320-73-4) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rosiglitazone (CAS 122320-73-4) as of 2021)

Table 23. Rosiglitazone (CAS 122320-73-4) Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Rosiglitazone (CAS 122320-73-4) Product Offered

Table 25. Date of Manufacturers Enter into Rosiglitazone (CAS 122320-73-4) Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2022) & (Kg)

Table 28. Global Rosiglitazone (CAS 122320-73-4) Sales by Type (2023-2028) & (Kg)

Table 29. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Type (2017-2022)

Table 30. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Type (2023-2028)

Table 31. Global Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2022) & (US$ Million)

Table 32. Global Rosiglitazone (CAS 122320-73-4) Revenue by Type (2023-2028) & (US$ Million)

Table 33. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Type (2017-2022)

Table 34. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Type (2023-2028)

Table 35. Rosiglitazone (CAS 122320-73-4) Price by Type (2017-2022) & (USD/Kg)

Table 36. Global Rosiglitazone (CAS 122320-73-4) Price Forecast by Type (2023-2028) & (USD/Kg)

Table 37. Global Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2022) & (Kg)

Table 38. Global Rosiglitazone (CAS 122320-73-4) Sales by Application (2023-2028) & (Kg)

Table 39. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Application (2017-2022)

Table 40. Global Rosiglitazone (CAS 122320-73-4) Sales Share by Application (2023-2028)

Table 41. Global Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2022) & (US$ Million)

Table 42. Global Rosiglitazone (CAS 122320-73-4) Revenue by Application (2023-2028) & (US$ Million)

Table 43. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Application (2017-2022)

Table 44. Global Rosiglitazone (CAS 122320-73-4) Revenue Share by Application (2023-2028)

Table 45. Rosiglitazone (CAS 122320-73-4) Price by Application (2017-2022) & (USD/Kg)

Table 46. Global Rosiglitazone (CAS 122320-73-4) Price Forecast by Application (2023-2028) & (USD/Kg)

Table 47. North America Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2022) & (Kg)

Table 48. North America Rosiglitazone (CAS 122320-73-4) Sales by Type (2023-2028) & (Kg)

Table 49. North America Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2022) & (US$ Million)

Table 50. North America Rosiglitazone (CAS 122320-73-4) Revenue by Type (2023-2028) & (US$ Million)

Table 51. North America Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2022) & (Kg)

Table 52. North America Rosiglitazone (CAS 122320-73-4) Sales by Application (2023-2028) & (Kg)

Table 53. North America Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2022) & (US$ Million)

Table 54. North America Rosiglitazone (CAS 122320-73-4) Revenue by Application (2023-2028) & (US$ Million)

Table 55. North America Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2022) & (Kg)

Table 56. North America Rosiglitazone (CAS 122320-73-4) Sales by Country (2023-2028) & (Kg)

Table 57. North America Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2022) & (US$ Million)

Table 58. North America Rosiglitazone (CAS 122320-73-4) Revenue by Country (2023-2028) & (US$ Million)

Table 59. Europe Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2022) & (Kg)

Table 60. Europe Rosiglitazone (CAS 122320-73-4) Sales by Type (2023-2028) & (Kg)

Table 61. Europe Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2022) & (US$ Million)

Table 62. Europe Rosiglitazone (CAS 122320-73-4) Revenue by Type (2023-2028) & (US$ Million)

Table 63. Europe Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2022) & (Kg)

Table 64. Europe Rosiglitazone (CAS 122320-73-4) Sales by Application (2023-2028) & (Kg)

Table 65. Europe Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2022) & (US$ Million)

Table 66. Europe Rosiglitazone (CAS 122320-73-4) Revenue by Application (2023-2028) & (US$ Million)

Table 67. Europe Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2022) & (Kg)

Table 68. Europe Rosiglitazone (CAS 122320-73-4) Sales by Country (2023-2028) & (Kg)

Table 69. Europe Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2022) & (US$ Million)

Table 70. Europe Rosiglitazone (CAS 122320-73-4) Revenue by Country (2023-2028) & (US$ Million)

Table 71. Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2022) & (Kg)

Table 72. Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Type (2023-2028) & (Kg)

Table 73. Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2022) & (US$ Million)

Table 74. Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Type (2023-2028) & (US$ Million)

Table 75. Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2022) & (Kg)

Table 76. Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Application (2023-2028) & (Kg)

Table 77. Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2022) & (US$ Million)

Table 78. Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Application (2023-2028) & (US$ Million)

Table 79. Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Region (2017-2022) & (Kg)

Table 80. Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Region (2023-2028) & (Kg)

Table 81. Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Region (2017-2022) & (US$ Million)

Table 82. Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Region (2023-2028) & (US$ Million)

Table 83. Latin America Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2022) & (Kg)

Table 84. Latin America Rosiglitazone (CAS 122320-73-4) Sales by Type (2023-2028) & (Kg)

Table 85. Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2022) & (US$ Million)

Table 86. Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Type (2023-2028) & (US$ Million)

Table 87. Latin America Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2022) & (Kg)

Table 88. Latin America Rosiglitazone (CAS 122320-73-4) Sales by Application (2023-2028) & (Kg)

Table 89. Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2022) & (US$ Million)

Table 90. Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Application (2023-2028) & (US$ Million)

Table 91. Latin America Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2022) & (Kg)

Table 92. Latin America Rosiglitazone (CAS 122320-73-4) Sales by Country (2023-2028) & (Kg)

Table 93. Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2022) & (US$ Million)

Table 94. Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Country (2023-2028) & (US$ Million)

Table 95. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2022) & (Kg)

Table 96. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Type (2023-2028) & (Kg)

Table 97. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2022) & (US$ Million)

Table 98. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Type (2023-2028) & (US$ Million)

Table 99. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2022) & (Kg)

Table 100. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Application (2023-2028) & (Kg)

Table 101. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2022) & (US$ Million)

Table 102. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Application (2023-2028) & (US$ Million)

Table 103. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2022) & (Kg)

Table 104. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Country (2023-2028) & (Kg)

Table 105. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2022) & (US$ Million)

Table 106. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Country (2023-2028) & (US$ Million)

Table 107. Hengrui Pharma Corporation Information

Table 108. Hengrui Pharma Description and Major Businesses

Table 109. Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 110. Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Hengrui Pharma Recent Developments

Table 112. GSK Corporation Information

Table 113. GSK Description and Major Businesses

Table 114. GSK Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 115. GSK Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. GSK Recent Developments

Table 117. Taiji Group Corporation Information

Table 118. Taiji Group Description and Major Businesses

Table 119. Taiji Group Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 120. Taiji Group Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Taiji Group Recent Developments

Table 122. Shengjitang Pharma Corporation Information

Table 123. Shengjitang Pharma Description and Major Businesses

Table 124. Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 125. Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Shengjitang Pharma Recent Developments

Table 127. Huanghe Pharma Corporation Information

Table 128. Huanghe Pharma Description and Major Businesses

Table 129. Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 130. Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Huanghe Pharma Recent Developments

Table 132. Wanma Pharma Corporation Information

Table 133. Wanma Pharma Description and Major Businesses

Table 134. Wanma Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 135. Wanma Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Wanma Pharma Recent Developments

Table 137. Jingxin Pharma Corporation Information

Table 138. Jingxin Pharma Description and Major Businesses

Table 139. Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 140. Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Jingxin Pharma Recent Developments

Table 142. STADA Corporation Information

Table 143. STADA Description and Major Businesses

Table 144. STADA Rosiglitazone (CAS 122320-73-4) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 145. STADA Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. STADA Recent Developments

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Rosiglitazone (CAS 122320-73-4) Distributors List

Table 150. Rosiglitazone (CAS 122320-73-4) Customers List

Table 151. Rosiglitazone (CAS 122320-73-4) Market Trends

Table 152. Rosiglitazone (CAS 122320-73-4) Market Drivers

Table 153. Rosiglitazone (CAS 122320-73-4) Market Challenges

Table 154. Rosiglitazone (CAS 122320-73-4) Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

List of Figures

Figure 1. Rosiglitazone (CAS 122320-73-4) Product Picture

Figure 3. Global Rosiglitazone (CAS 122320-73-4) Market Share by Type in 2021 & 2028

Figure 3. Rosiglitazone Tablets Product Picture

Figure 4. Rosiglitazone Maleate Tablets Product Picture

Figure 5. Rosiglitazone Hydrochloride Tablets Product Picture

Figure 6. Others Product Picture

Figure 7. Global Rosiglitazone (CAS 122320-73-4) Market Share by Application in 2021 & 2028

Figure 8. Hospital Pharmacies

Figure 9. Retail Pharmacies

Figure 10. Online Pharmacies

Figure 11. Rosiglitazone (CAS 122320-73-4) Report Years Considered

Figure 12. Global Rosiglitazone (CAS 122320-73-4) Sales 2017-2028 (Kg)

Figure 13. Global Rosiglitazone (CAS 122320-73-4) Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global Rosiglitazone (CAS 122320-73-4) Revenue 2017-2028 (US$ Million)

Figure 15. Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 16. Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Region (2017-2022)

Figure 17. Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Region (2023-2028)

Figure 18. North America Rosiglitazone (CAS 122320-73-4) Sales YoY (2017-2028) & (Kg)

Figure 19. North America Rosiglitazone (CAS 122320-73-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Europe Rosiglitazone (CAS 122320-73-4) Sales YoY (2017-2028) & (Kg)

Figure 21. Europe Rosiglitazone (CAS 122320-73-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Asia-Pacific Rosiglitazone (CAS 122320-73-4) Sales YoY (2017-2028) & (Kg)

Figure 23. Asia-Pacific Rosiglitazone (CAS 122320-73-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Latin America Rosiglitazone (CAS 122320-73-4) Sales YoY (2017-2028) & (Kg)

Figure 25. Latin America Rosiglitazone (CAS 122320-73-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 26. Middle East & Africa Rosiglitazone (CAS 122320-73-4) Sales YoY (2017-2028) & (Kg)

Figure 27. Middle East & Africa Rosiglitazone (CAS 122320-73-4) Revenue YoY (2017-2028) & (US$ Million)

Figure 28. The Rosiglitazone (CAS 122320-73-4) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 29. The Top 5 and 10 Largest Manufacturers of Rosiglitazone (CAS 122320-73-4) in the World: Market Share by Rosiglitazone (CAS 122320-73-4) Revenue in 2021

Figure 30. Global Rosiglitazone (CAS 122320-73-4) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 31. Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2017-2028)

Figure 32. Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Type (2017-2028)

Figure 33. Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2017-2028)

Figure 34. Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Application (2017-2028)

Figure 35. North America Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2017-2028)

Figure 36. North America Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Type (2017-2028)

Figure 37. North America Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2017-2028)

Figure 38. North America Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Application (2017-2028)

Figure 39. North America Rosiglitazone (CAS 122320-73-4) Sales Share by Country (2017-2028)

Figure 40. North America Rosiglitazone (CAS 122320-73-4) Revenue Share by Country (2017-2028)

Figure 41. U.S. Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 42. Canada Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 43. Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2017-2028)

Figure 44. Europe Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Type (2017-2028)

Figure 45. Europe Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2017-2028)

Figure 46. Europe Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Application (2017-2028)

Figure 47. Europe Rosiglitazone (CAS 122320-73-4) Sales Share by Country (2017-2028)

Figure 48. Europe Rosiglitazone (CAS 122320-73-4) Revenue Share by Country (2017-2028)

Figure 49. Germany Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 50. France Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 51. U.K. Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 52. Italy Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 53. Russia Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 54. Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2017-2028)

Figure 55. Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Type (2017-2028)

Figure 56. Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2017-2028)

Figure 57. Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Application (2017-2028)

Figure 58. Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales Share by Region (2017-2028)

Figure 59. Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue Share by Region (2017-2028)

Figure 60. China Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 61. Japan Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 62. South Korea Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 63. India Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 64. Australia Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 65. Taiwan Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 66. Indonesia Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 67. Thailand Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 68. Malaysia Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 69. Philippines Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 70. Latin America Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2017-2028)

Figure 71. Latin America Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Type (2017-2028)

Figure 72. Latin America Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2017-2028)

Figure 73. Latin America Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Application (2017-2028)

Figure 74. Latin America Rosiglitazone (CAS 122320-73-4) Sales Share by Country (2017-2028)

Figure 75. Latin America Rosiglitazone (CAS 122320-73-4) Revenue Share by Country (2017-2028)

Figure 76. Mexico Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 77. Brazil Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 78. Argentina Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 79. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Type (2017-2028)

Figure 81. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales Share by Country (2017-2028)

Figure 84. Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue Share by Country (2017-2028)

Figure 85. Turkey Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 86. Saudi Arabia Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 87. U.A.E Rosiglitazone (CAS 122320-73-4) Revenue (2017-2028) & (US$ Million)

Figure 88. Rosiglitazone (CAS 122320-73-4) Value Chain

Figure 89. Rosiglitazone (CAS 122320-73-4) Production Process

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Rosiglitazone (CAS 122320-73-4) Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-29L7283

Global Rosiglitazone (CAS 122320-73-4) Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26X5859

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-6F14217

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-12I6253

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-10Q6255

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions